Seeking Alpha

Mike Havrilla » Articles » ADLS |

  • Pending FDA Decisions: 20 Extreme Trades
    on Jun 22, 2009 • ACUR, ADLS, APPA    
  • 13 Extreme FDA Trades
    on Jun 02, 2009 • ABIO, ADLS, APPA    
  • Pending FDA Decisions: 12 Extreme Trades
    on May 20, 2009 • ABIO, ADLS, BDSI    
  • Vanda Pharma: An Extreme FDA Trade That Paid; 9 More to Go
    on May 07, 2009 • ABIO, ACUS, ADLS    
  • 12 Extreme FDA Trades on New Product Decisions
    on Apr 09, 2009 • ACUS, ADLS, BDSI    
  • Trading FDA Decisions: 14 Candidates
    on Mar 12, 2009 • ABIO, ADLS, BDSI    
  • Bio-Pharma, Diagnostics Buyout Binge Begins
    on Jan 11, 2009 • ADLS, BDSI, BMY    
  • Weekly FDA Calendar Update
    on Dec 07, 2008 • ADLS, AGN, AZN    
  • Top 10 Emerging Biotech Stocks
    on Oct 15, 2007 • ADLS, EXAS, GTCB    
  • Advanced Life Sciences Attractive After Recent Sell-Off
    on Jun 29, 2007 • ADLS    
More on ADLS by Mike Havrilla
Articles by Ticker
AA, AAI, AAPL, AAWW, ABBC, ABFS, ABII, ABIO, ABMD, ABT, ABTL, ABV, ABX, ACAD, ACCP.OB, ACEL, ACHN, ACL, ACLI, ACOR, ACTC, ACTC.PK, ACUR, ACUS, ADAM, ADLR, ADLS, ADLS.OB, AET, AEZS, AFFX, AFFY, AFL, AGEN, AGN, AHBIF.PK, AIQ, AIRM, AIS, AKRX, ALEX, ALGT, ALK, ALKS, ALNPY.PK, ALNY, ALO, ALPMF.PK, ALTH, ALV,

Latest Comments on Mike Havrilla's Articles

  1. saber Tooth on Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System: Huge potential market and many companys both private and public... more »
  2. Evelyn Guzman on Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System: I hope everything goes well with the development of this product... more »
  3. The Watchful Eye on BioMed News Bytes: Cytori, Questcor: QCOR estimates that as many as 2,000 children annually experience... more »
  4. jimmy Turano on BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI: MIKE HAVRILLA-Let me be the first to wish you a Happy Thanksgiving... more »
  5. unblock school on Novartis: An Ex-U.S. Proxy for Global Healthcare: Thanks for great post Mike, Delta more »
  6. drgmoney on Access Pharma Looking for Smooth U.S. MuGard Launch in 2010: Do you know if the post marketing Data on Mugard in Europe will be... more »
  7. jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: Thanks Charlie - I didn't know the stats off the top of my head... more »
  8. Super Stock Timer on BioMed News Bytes: Cytori, Questcor: 11-7-09 - BUY DNDN ON THE FIRST CLOSE ABOVE 29.00 - WALTER - SUPER... more »
  9. Charlie L on EXACT Sciences: Buy and Hold for Long-Term Upside: Agree that $300 every 3 years is a bargain compared to a $2,000... more »
  10. jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: $300 per test is an absolute bargain to detect CRC early. the... more »
  11. BioGuy on A 130 / 30 Global Pharma Strategy : Good ideas, the generic pharmaceutical market will do well. My... more »
  12. Dr. Bone on A 130 / 30 Global Pharma Strategy : This index sounds very interesting. Is there a way you can... more »
  13. TX Gal 4Evr on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Have you not heard of 'change' or 'growth' or 'variety'?? It's... more »
  14. dual cit on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Not what I want to hear from you. I have grown accustomed to you... more »
  15. hoopdreamerz@yahoo.com on EXACT Sciences: Patience Required for Long-Term Upside: That's funny they compared their data with OncoMethylone (i had... more »